nach oben

Current Heart Failure Reports

Erschienen in:

01.04.2015 | Management of Heart Failure (TE Meyer, Section Editor)

Tricuspid Valve Incompetence Following Implantation of Ventricular Leads

verfasst von: Giselle A. Baquero, Jerry Luck, Gerald V. Naccarelli, Mario D. Gonzalez, Javier E. Banchs

Erschienen in: Current Heart Failure Reports | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Most cardiovascular implantable electronic devices (CIEDs) require a ventricular lead to be placed across the tricuspid valve. Tricuspid regurgitation (TR) is an understudied clinical complication of right ventricular lead implantation and its clinical significance is unknown. We review the incidence, predictors, and current management of TR as a complication of ventricular lead implantation. Emerging technologies, including leadless pacing devices and subcutaneous systems, offer the benefit of little or none tricuspid valve disruption.

Kikuchi Y, Shiraishi H, Igarashi H, Yanagisawa M. Insertion of a pacing lead via the tricuspid valve does not affect cardiac function and tricuspid valve regurgitation in young dogs. Acta Paediatr Jpn. 1996;38(1):32.CrossRefPubMed

Morgan DE, Norman R, West RO, Burggraf G. Echocardiographic assessment of tricuspid regurgitation during ventricular demand pacing. Am J Cardiol. 1986;58(10):1025–9.CrossRefPubMed

Kucukarslan N, Kirilmaz A, Ulusoy E, Yokusoglu M, Gramatnikovski N, Ozal E, et al. Tricuspid insufficiency does not increase early after permanent implantation of pacemaker leads. J Card Surg. 2006;21(4):391–4.CrossRefPubMed

Leibowitz DW, Rosenheck S, Pollak A, Geist M, Gilon D. Transvenous pacemaker leads do not worsen tricuspid regurgitation: a prospective echocardiographic study. Cardiology. 2000;93(1–2):74–7.CrossRefPubMed

Webster G, Margossian R, Alexander ME, Cecchin F, Triedman JK, Walsh EP, et al. Impact of transvenous ventricular pacing leads on tricuspid regurgitation in pediatric and congenital heart disease patients. J Interv Card Electrophysiol. 2008;21(1):65–8.CrossRefPubMedCentralPubMed

6.•

Al-Mohaissen MA, Chan KL. Prevalence and mechanism of tricuspid regurgitation following implantation of endocardial leads for pacemaker or cardioverter-defibrillator. J Am Soc Echocardiogr. 2012;25:245–52. This is a well written review revealing the prevalence and studying the mechanism of tricuspid regurgitation following implantation of endocardial leads for pacemakers or cardioverter-defibrillators.CrossRefPubMed

Sakai M, Ohkawa S, Ueda K, Kin H, Watanabe C, Matsushita S, et al. Tricuspid regurgitation induced by transvenous right ventricular pacing: echocardiographic and pathological observations. J Cardiol. 1987;17(2):311–20.PubMed

Paniagua D, Aldrich HR, Lieberman EH, Lamas GA, Agatston AS. Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. Am J Cardiol. 1998;82(9):1130. -2, A9.CrossRefPubMed

Lin G, Nishimura RA, Connolly HM, Dearani JA, Sundt 3rd TM, Hayes DL. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J Am Coll Cardiol. 2005;45(10):1672–5.CrossRefPubMed

10.

Kim JB, Spevack DM, Tunick PA, Bullinga JR, Kronzon I, Chinitz LA, et al. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study. J Am Soc Echocardiogr. 2008;21(3):284–7.CrossRefPubMed

11.

Klutstein M, Balkin J, Butnaru A, Ilan M, Lahad A, Rosenmann D. Tricuspid incompetence following permanent pacemaker implantation. Pacing Clin Electrophysiol. 2009;32 Suppl 1:S135–7.CrossRefPubMed

12.

Vaturi M, Kusniec J, Shapira Y, Nevzorov R, Yedidya I, Weisenberg D, et al. Right ventricular pacing increases tricuspid regurgitation grade regardless of the mechanical interference to the valve by the electrode. Eur J Echocardiogr. 2010;11(6):550–3.CrossRefPubMed

13.

Alizadeh A, Sanati HR, Haji-Karimi M, Yazdi AH, Rad MA, Haghjoo M, et al. Induction and aggravation of atrioventricular valve regurgitation in the course of chronic right ventricular apical pacing. Europace. 2011;13(11):1587–90. Epub 2011 Jul 8.CrossRefPubMed

14.••

Baquero GA, Yadav P, Skibba JB, Banchs JE, Linton-Frazier LN, Lengerich EJ, et al. Clinical significance of increased tricuspid valve incompetence following implantation of ventricular leads. J Interv Card Electrophysiol. 2013;38(3):197–202. This study is the first to demonstrate an association between the development of tricuspid regurgitation following implantation of cardiovascular implantable electronic devices and subsequent increased hospitalizations for heart failure exacerbation.CrossRefPubMed

15.

Rajappan K. Permanent pacemaker implantation technique: part II. Heart. 2009;95:334–42.CrossRefPubMed

16.••

Mediratta A, Addetia K, Yamat M, Moss JD, Nayak HM, Burke MC, Weinert L, Maffessanti F, Jeevanandam V, Mor-Avi V, Lang RM. 3D Echocardiographic Location of Implantable Device Leads and Mechanism of Associated Tricuspid Regurgitation. JACC Cardiovasc Imaging. 2014 Mar 7 [Epub ahead of print].This is the first study depicting mechanical interference of implantable device leads by 3D echocardiography as mechanism of tricuspid regurgitation in this patient population.

17.

Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999;83:897–902.CrossRefPubMed

18.

Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J. 2002;144:524–9.CrossRefPubMed

19.

D’Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med. 1991;115:343–9.CrossRefPubMed

20.

Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43(3):405–9.CrossRefPubMed

21.

Robboy SJ, Harthorne JW, Leinbach RC, Sanders CA, Austen WG. Autopsy findings with permanent pervenous pacemakers. Circulation. 1969;39(4):495–501.CrossRefPubMed

22.•

Rainer PP, Schmidt A, Anelli-Monti M, Kleinert R, Pieske BM, Maier RM. A swinging pacemaker lead promoting endocarditis and severe tricuspid regurgitation. J Am Coll Cardiol. 2012;59(23):e45. This is a case report that demonstrate an association between pacemaker lead endocarditis and the development of tricuspid regurgitation.CrossRefPubMed

23.

Lezzi F, Cini R, Sordini P. Tricuspid-valve repair for pacemaker leads endocarditis. BMJ Case Rep. 2010 Dec 20;2010.

24.•

Najib MQ, Vinales KL, Vittala SS, Challa S, Lee HR, HP C- l. Predictors for the development of severe tricuspid regurgitation with anatomically normal valve in patients with atrial fibrillation. Echocardiography. 2012;29(2):140–6. This study demonstrates an association between severe functional tricuspid regurgitation in older patients with chronic atrial fibrillation even in the presence of structurally normal tricuspid valves.CrossRefPubMed

25.•

Najib MQ, Vittala SS, Challa S, Raizada A, Tondato FJ, Lee HR, et al. Predictors of severe tricuspid regurgitation in patients with permanent pacemaker or automatic implantable cardioverter-defibrillator leads. Tex Heart Inst J. 2013;40(5):529–33. In this study the authors were able to demonstrate an association between atrial fibrillation and longer durations of lead placement and the development of severe tricuspid regurgitation in patients with permanent pacemakers.PubMedCentralPubMed

26.

Seo Y, Ishizu T, Nakajima H, Sekiguchi Y, Watanabe S, Aonuma K. Clinical utility of 3-dimensional echocardiography in the evaluation of tricuspid regurgitation caused by pacemaker leads. Circ J. 2008;72(9):1465–70.CrossRefPubMed

27.

Nucifora G, Badano LP, Allocca G, Gianfagna P, Proclemer A, Cinello M, et al. Severe tricuspid regurgitation due to entrapment of the anterior leaflet of the valve by a permanent pacemaker lead: Role of real time three-dimensional echocardiography. Echocardiography. 2007;24:649–52.CrossRefPubMed

28.

Küpper B, Yee R, O'Hara G, Simpson CS, Della Bella P, Workel M, et al. Do small (6.6 Fr.) active and passive fixation defibrillation leads perform as well as larger sized leads? A multi-centre analysis. Europace. 2007;9(8):657–61.CrossRefPubMed

29.

Hauser RG, Kallinen LM, Almquist AK, Gornick CC, Katsiyiannis WT. Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm. 2007;4(7):892–6.CrossRefPubMed

30.

Cantù F, De Filippo P, Gabbarini F, Borghi A, Brambilla R, Ferrero P, et al. Selective-site pacing in paediatric patients: a new application of the Select Secure system. Europace. 2009;11(5):601–6.CrossRefPubMed

31.•

Auricchio A, Delnoy PP, Regoli F, Seifert M, Markou T, Butter C, et al. First-in-man implantation of leadless ultrasound-based cardiac stimulation pacing system: novel endocardial left ventricular resynchronization therapy in heart failure patients. Europace. 2013;15(8):1191–7. This study describes the first-in-man experience of chronically implanted, leadless pacing achieved using a novel wireless technology based on converting ultrasound energy to electrical energy.CrossRefPubMed

32.••

Reddy VY, Knops RE, Sperzel J, Miller MA, Petru J, Simon J, et al. Permanent leadless cardiac pacing: results of the LEADLESS trial. Circulation. 2014;129(14):1466–71. This is the first prospective nonrandomized study that demonstrated the safety and feasibility of placing a catheter delivered self-contained unit, single-chamber leadless cardiac pacemaker.CrossRefPubMed

33.••

Auricchio A, Delnoy PP, Butter C, Brachmann J, Van Erven L, Spitzer S, et al. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the Wireless Stimulation Endocardially for CRT (WiSE-CRT) study. Europace. 2014;16(5):681–8. This study demonstrates the feasibility of providing endocardial stimulation for CRT with a leadless technology.CrossRefPubMed

34.••

Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013;128(9):944–53. This study demonstrated the efficacy and safety of an implantable subcutaneous defibrillator for the treatment of life-threatening ventricular arrhythmias.CrossRefPubMed

35.

Bai Y, Strathmore N, Mond H, Grigg L, Hunt D. Permanent ventricular pacing via the great cardiac vein. Pacing Clin Electrophysiol. 1994;17(4 Pt 1):678–83.CrossRefPubMed

36.

Leng CT, Crosson JE, Calkins H, Berger RD. Lead configuration for defibrillator implantation in a patient with congenital heart disease and a mechanical prosthetic tricuspid valve. Pacing Clin Electrophysiol. 2001;24(8 Pt 1):1291–2.CrossRefPubMed

37.

Curnis A, Mascioli G, Bianchetti F, Bontempi L, Marconi R, D'Aloia A, et al. Implantation of a single chamber pacemaker in patients with triple mechanical valve prosthesis: utilization of coronary sinus distal branches to stimulate the left ventricle. Pacing Clin Electrophysiol. 2002;25(2):239–40.CrossRefPubMed

38.•

Lopez JA. Implantable cardioverter defibrillator lead placement in the middle cardiac vein after tricuspid valve surgery. Europace. 2012;14(6):853–8. This case demonstrate the feasibility and safety of using the cardiac venous system for permanent pacing as an alternative to epicardial lead placement in patients for whom RV lead placement is contraindicated or impossible.CrossRefPubMed

39.

Murayama H, Maeda M, Sakurai H, Usui A, Ueda Y. Predictors affecting durability of epicardial pacemaker leads in pediatric patients. J Thorac Cardiovasc Surg. 2008;135(2):361–6.CrossRefPubMed

Titel: Tricuspid Valve Incompetence Following Implantation of Ventricular Leads
verfasst von: Giselle A. Baquero
Jerry Luck
Gerald V. Naccarelli
Mario D. Gonzalez
Javier E. Banchs
Publikationsdatum: 01.04.2015
Verlag: Springer US
Erschienen in: Current Heart Failure Reports / Ausgabe 2/2015
Print ISSN: 1546-9530
Elektronische ISSN: 1546-9549
DOI: https://doi.org/10.1007/s11897-014-0249-x

Neu im Fachgebiet Kardiologie

19.04.2024 | Vorhofflimmern | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Tricuspid Valve Incompetence Following Implantation of Ventricular Leads

Abstract

Neu im Fachgebiet Kardiologie

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Kardiologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2015

Current Practice in Patient Selecting for Long-Term Mechanical Circulatory Support

Role of Thyroid Hormones in Ventricular Remodeling

Pathophysiology of Sepsis-Related Cardiac Dysfunction: Driven by Inflammation, Energy Mismanagement, or Both?

Technology-Assisted Congestive Heart Failure Care

Can Cognitive Behaviour Therapy Be Beneficial for Heart Failure Patients?

Altered Breathing Syndrome in Heart Failure: Newer Insights and Treatment Options

Neu im Fachgebiet Kardiologie

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Kardiologie